Antiinsomniac therapy in patients with refractory nocturia and benign prostatic hyperplasia

Автор: Shestaev A.ytT., Protoschak V.V., Gordeev V.V., Matich A.I., Gunko A.M.

Журнал: Экспериментальная и клиническая урология @ecuro

Рубрика: Андрология

Статья в выпуске: 3, 2016 года.

Бесплатный доступ

Introduction. One of the most common multifactorial disease states, which is caused by certain systemic diseases, as well as the reception of drugs and psycho-emotional status of the person is insomnia. Materials and methods. Palpitations nighttime urination - is the most common reason for seeking medical care for patients suffering from lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Nocturia and insomnia are interrelated pathological states, each of which contributes significantly to the decline in the quality of life of patients, which manifests itself daily dysfunction and impaired social and occupational functioning. Currently, there are two points of view on the cause nocturia and insomnia. The first - a "urological theory" that shows that the cause of insomnia showing frequent nighttime urination. The second belongs to the professionals involved in the problems of sleep disturbance claim that nocturia is due to insomnia. Results and discussion. The results of the combined alpha-adrenolitic and antiinsomniac therapy of patients with lower urinary tract symptoms / benign prostatic hyperplasia on the background of refractory nocturia. Conclusion. It is proved that supplementation hypnotic drug (zaleplon) in the treatment of LUTS/ BPH is an effective and safe way to correct refractory nocturia in patients with concomitant insomnia.

Еще

Nocturia, insomnia, sleep quality, daytime dysfunction, athens scale of insomnia, zaleplon, tamsulosin

Короткий адрес: https://sciup.org/142188138

IDR: 142188138

Статья научная